Health & Fit New South Wales Eyes More Pfizer for Vaccine Plan: SMH
Johnson & Johnson Is Working on a COVID-19 Vaccine That Requires a Single Dose
It’s still in phase 3 clinical trials, but the early data is promising, experts say.Interim phase 1/2a data were published on Jan. 13 in the New England Journal of Medicine, and the results show the company’s vaccine candidate created an immune response in patients for at least 71 days—the full length of time measured in the study so far.
(Bloomberg) -- Australia’s most populous state is planning a major overhaul of its Covid-19 inoculation program, including a possible increase in the volume of Pfizer Inc.’s doses and distribution of new alternative vaccines, the Sydney Morning Herald reported.
The strategy in New South Wales is under review ahead of Monday’s national cabinet meeting, which is also likely to address the future of the rollout of AstraZeneca Plc’s shots for people over 50 years of age, the paper said.
Pfizer says its vaccine works against key coronavirus mutations found on the South Africa and UK variants
Pfizer tested its coronavirus vaccine against lab-made viruses designed to mimic the variants found in the UK and South Africa.Studies conducted by Pfizer and the University of Texas showed "small differences" in how well antibodies produced by Pfizer's vaccine bound to and killed the lab-made viruses, compared to how well they worked against the original virus.
The pivot comes as the Therapeutic Goods Administration noted a likely link between the AstraZeneca dose and the death of a 48-year-old woman in New South Wales, the third case of blood clotting associated with the vaccine. The federal government faces continued criticism over delays in the country’s rollout, with Prime Minister Scott Morrison this weeka new target date for all Australians to receive their first shot.
About 1.2 million people in the nation of 25.8 million have received a first vaccine dose.
The NSW government reported no new locally-acquired cases of Covid-19 in the 24 hours, and seven new cases among those arriving into the country, bringing total infections in the state since the beginning of the pandemic to 5,181.
(Corrects story that moved on April 17 that misstated the number of deaths linked to the vaccine in the third paragraph.)
For more articles like this, please visit us at
©2021 Bloomberg L.P.
COVID Variant Can "Break Through" This Vaccine, Says Alarming New Study .
According to a new study, the South African variant of COVID-19 has a greater likelihood of “breaking through” the Pfizer vaccine.According to the new study, conducted by Tel Aviv University and Clalit and involving the test results of 800 people, the South African variant, B.1.351, has a greater likelihood of "breaking through" the Pfizer vaccine compared to the other variants. The researchers claim that of the 800 people, half tested positive for the virus over 14 days after receiving at least one dose. The other half were those who were unvaccinated, but tested positive.